Corporate digest
Add BT as a preferred sourceBiolidics
CATALIST-LISTED medtech firm Biolidics announced on Wednesday (Dec 29) that its wholly-owned subsidiary, Biomedics Laboratory, has been granted approval by the Ministry of Health (MOH) to provide medical microbiology services, including Covid-19 polymerase chain reaction (PCR) tests.
Subject to the company being able to secure sales for its testing services, Biolidics expects the MOH approval to contribute positively to the revenue of the group amid the Covid-19 pandemic for the financial year ending Dec 31, 2022.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential legal liabilities
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
Anytime Fitness Asia’s owner said to weigh US$400 million sale
